RayzeBio, Inc. IPO Research Information

RayzeBio, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on RayzeBio, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
RayzeBio, Inc.	RYZB -	$16.00-$18.00	$18.00	$25.00	17.3 million	9/15/2023
Underwriter(s): J.P. Morgan, Jefferies, Evercore ISI, Truist Securities
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2023-08-24 Terms Added 2023-09-11

RayzeBio, Inc. Quote & Chart - Click for current quote - RYZB

About RayzeBio, Inc. (adapted from RayzeBio, Inc. prospectus):
They are building a vertically integrated radiopharmaceutical therapeutics company with our lead program in a Phase 3 clinical trial.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RYZB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.